2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 131 filers reported holding 2SEVENTY BIO INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $385 | -95.9% | 100 | -95.8% | 0.00% | – |
| Q3 2023 | $9,416 | -63.2% | 2,402 | -5.0% | 0.00% | – |
| Q2 2023 | $25,583 | +747.4% | 2,528 | +754.1% | 0.00% | – |
| Q1 2023 | $3,019 | +20.2% | 296 | +10.4% | 0.00% | – |
| Q4 2022 | $2,511 | -49.8% | 268 | -23.9% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 352 | -47.5% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 670 | +29.8% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 516 | +24.3% | 0.00% | – |
| Q4 2021 | $11,000 | – | 415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |